"Risk Management + Post-Market Safety Strategies = Improved Financial Ratings"
On March 1 Standard & Poor's implemented new credit rating rules around Enterprise Risk Management Analysis for Nonfinancial Companies. WATERMARK's white paper explains how a safety oversight strategy can help mitigate risks for pharma, biotech and medical device companies.
"So You Have an Outcome Registry, Now What? Practical Tips to Registry Administration"
Robust risk management strategies include outcome registries used to collect safety, efficacy, clinical benefit, and QOL information. Independence of the data and regulatory scrutiny should be considered. This WATERMARK white paper provides tips for administration of a registry.